Rachit Khandelwal/X
Feb 4, 2025, 22:31
Rachit Khandelwal: Targeting CD47 – many misses, hopeful for a hit
Rachit Khandelwal, Pediatrics BMT fellow at Medanta The Medicity, Gurgaon, shared a post on X:
“Targeting CD47: many misses; hopeful for a hit.
In vivo efficacy of a novel, bivalent CD47 immunotoxin used as targeted therapy for T-cell acute lymphoblastic leukemia in a mouse model.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 7, 2025, 17:41
Jun 7, 2025, 16:47
Jun 7, 2025, 16:40
Jun 7, 2025, 16:30
Jun 7, 2025, 16:07
Jun 7, 2025, 15:49